Skip to main content
. 2024 Jan 29;43(5):754–779. doi: 10.1038/s44318-024-00036-1

Figure 6. Selection and validation of OPTN monobodies.

Figure 6

(A) Schematic representation of the process to select monobodies against OPTN using TRAP display. The BC, CD, and FG loops in the monobody structure (PDB: 1TTG) are shown in orange. (B) NDP52 KO HeLa cells expressing Parkin, mt-Keima, and YFP or YFP-tagged monobodies (MonoB) were treated with antimycin A and oligomycin (AO) for 5 h and analyzed by FACS. Representative FACS data with the percentage of cells exhibiting lysosomal positive mt-Keima are shown. (C) Mitophagy rate (percentage of cells having lysosomal positive Keima) in (B) were quantified. Error bars represent mean ± s.d. of four independent experiments. (D) Mitophagy rate (percentage of cells having lysosomal positive Keima) using OPTN KO HeLa cells were quantified. Error bars represent mean ± s.d. of four independent experiments. (E) NDP52 KO HeLa cells expressing Parkin and YFP or YFP-tagged MonoB were analyzed by immunoblotting (IB). (F) The cells in (E) were co-immunoprecipitated (co-IP) using GFP-Trap. The bound fractions were analyzed by IB. (G) Recombinant GST-OPTN (26–196 aa, 26–119 aa, or 133–196 aa) were incubated with recombinant MonoB. The glutathione sepharose bound fractions were analyzed by CBB staining. (H) Recombinant GST-TBK1 (677–729 aa) and MonoB were incubated with either recombinant GFP or OPTN (26–196 aa)-GFP. GST-TBK1 (677–729 aa) was pulled down with glutathione sepharose and the bound fractions were analyzed by CBB staining. (I) The levels of OPTN (26–196 aa)-GFP pulled down with GST-TBK1 (677–729 aa) in (H) were quantified. The level of OPTN (26–196 aa)-GFP pulled down without MonoB was set to 100. Error bars represent mean ± s.d. of three independent experiments. Data information: n.s. not significant, *P < 0.05, ***P < 0.001 by two-tailed Dunnett’s test (C,D,I). Source data are available online for this figure.